Castle Biosciences Celebrates Fifth Consecutive USA TODAY Top Workplaces Award in 2026

Castle Biosciences, Inc., a leading company in health diagnostics known for its innovative testing solutions, proudly announces its remarkable achievement of being awarded the 2026 USA TODAY Top Workplaces USA Award. This marks the fifth consecutive year that the company has received this prestigious recognition, further solidifying its commitment to building a people-centric workplace culture.

Derek Maetzold, Castle's president and CEO, expressed gratitude for the continued recognition, stating, "Receiving a fifth straight Top Workplaces USA Award is a remarkable achievement and a direct reflection of the passion and dedication of our Castle team members, whose commitment to improving patient care inspires everything we do." This heartfelt acknowledgment speaks volumes about the company's unwavering focus on fostering a culture that values and empowers its employees. Building and nurturing such a culture, as noted by Maetzold, is not a one-off endeavor; it is an ongoing commitment that Castle actively pursues year after year.

The USA TODAY Top Workplaces program is an esteemed national accolade facilitated by Energage, a human resources research firm. Winners are determined solely through employee feedback collected via a confidential third-party survey. This rigorous methodology ensures that the awards are based on genuine employee experiences and sentiments about the workplace. Themes evaluated in the survey serve as proven indicators of high performance, contributing significantly to Castle's sustained success as a top employer.

Eric Rubino, CEO of Energage, highlighted the importance of the award as a testament to an organization's credibility, stating, "Earning a USA TODAY Top Workplaces award is a testament to an organization's credibility and commitment to a people-first culture. This award, driven by real employee feedback, is more than just an acknowledgment—it's proof that your employees believe in the organization and its leadership." Such recognition not only establishes trust but also serves as a powerful attractor for job seekers and customers alike, emphasizing the company’s dedication to valuing its people.

"Job seekers and customers look for this trusted badge of credibility and excellence," continues Rubino. This award acts as a beacon for those seeking environments that prioritize employee engagement and satisfaction, especially in today’s competitive job market. The full list of Top Workplaces for 2026 can be accessed at TopWorkplaces.com, showcasing organizations that excel in fostering favorable work environments.

Castle Biosciences, publicly traded on NASDAQ under the ticker CSTL, specializes in diagnostic testing aimed at enhancing health outcomes through innovative solutions. The company primarily focuses on dermatologic and gastroenterological diseases, developing personalized, clinically actionable tests that guide both patients and healthcare providers in making informed treatment decisions. By emphasizing rigorous scientific principles and advanced molecular tests, Castle strives to uplift the standard of patient care.

The company's dedication to employee welfare is exemplified by its ongoing commitment to ensure that team members feel valued, supported, and empowered. As articulated by Maetzold, earning and maintaining that trust is paramount to Castle’s philosophy, as it plays a crucial role in achieving overall success.

Castle Biosciences’ range of diagnostic tests, such as DecisionDx-Melanoma, DecisionDx-SCC, and MyPath Melanoma, not only represent technological advancements in the medical field but also reassert the company’s commitment to improving patient management and outcomes through diligent research and development. Their focus on personalized care reflects a deeper understanding of the complexities within health challenges faced by patients today.

The recognition received by Castle Biosciences is not just another accolade, but a reflection of the company’s philosophy to put people first. This ethos, intertwined with their mission to improve health through innovative testing solutions, continues to guide their journey into the future, ensuring that they remain a leader in patient-centric care within the diagnostics industry. With plans to further expand their innovative testing capabilities, Castle seeks to set new benchmarks in patient care in the years to come.

To stay updated with their initiatives and advancements, visit Castle Biosciences’ official website and follow their progress on various social media platforms like LinkedIn, Instagram, Facebook, and X.